Indication
Metastatic Malignant Neoplasm in the Viscera
1 clinical trial
2 products
1 drug
Clinical trial
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]Status: Active (not recruiting), Estimated PCD: 2024-09-15
Product
CabozantinibProduct
IpilimumabDrug
T-VEC